UArizona Health Sciences researchers uncover potential new therapy for concussion-related headaches

February 18, 2020

TUCSON, Ariz. - As she jumped to head a soccer ball during her junior year of college, Kelly Farrell collided skulls with a teammate. She later was diagnosed with a concussion, which proved to be severely debilitating.

"I had a lot of trouble concentrating in school and class," said Farrell, a physical therapist and Tucson native, who experienced a constant headache for two days after her concussion. Even after the initial pain subsided, her headache was reactivated by noise, bright light and studying on her computer.

Each year, traumatic brain injuries such as concussions cause nearly 2.5 million visits to an emergency room. The most common problem associated with concussions is headache. In an effort to develop a treatment, researchers at the University of Arizona College of Medicine - Tucson collaborated in a preclinical study with scientists at Teva Biologics and the Mayo Clinic to identify the cause of post-concussion headaches and a possible therapy for the millions of patients who experience this pain each year.

With Edita Navratilova, PhD, assistant professor in the Department of Pharmacology, as lead author and Frank Porreca, PhD, associate head of the department, as a co-author, the group published its findings in Cephalalgia in September 2019.

The scientists investigated whether a drug that blocks a substance elevated in migraine patients, calcitonin gene-related peptide (CGRP), would alleviate the headache pain by modeling human concussion in mice and assessing post-injury pain sensitivity. Researchers administered the anti-CGRP treatment twice - two hours and then seven days after the injury - and found the two doses significantly reduced pain responses.

In addition to immediate or acute headaches, long-lasting or persistent post-traumatic headaches affect injured patients, Dr. Porreca said.

Researchers assessed persistent post-traumatic headaches in their mouse model. Bright light reactivated headaches in injured mice 14 days after injury but caused no headaches in healthy mice.

To prevent stress-induced headaches, scientists administered an additional drug dose before the bright-light stress. When administered before the stress, in addition to after the injury, the drug not only prevented the immediate headache but also prevented bright light from reactivating the headache.

Researchers concluded that CGRP may be the link between traumatic brain injuries and post-injury headaches.

"The sustained prevention of the actions of CGRP with an antibody treatment administered early after a mild traumatic brain injury prevents post-traumatic headache in our preclinical model, as well as the vulnerability for development of persistent post-traumatic headache," Dr. Porreca said.

"The encouraging aspect is that we do have a mechanism which seems to be driving some aspect of the pain, and if treated at the right time in this preclinical model, it seems to be effective," Dr. Porreca said. Although the timing and dosage of the drug would need to be adapted to humans in future clinical trials, he added, it appears immediate treatment is critical to the therapy's success.
-end-
NOTE: Photos available upon request.

University of Arizona Health Sciences

Related Concussion Articles from Brightsurf:

Diagnosing sports-related concussion in teens
Researchers investigated the effectiveness of using measurements of how pupils react to light as physiologic biomarker to help diagnose sports-related concussion in adolescents.

Should you really be behind the wheel after concussion?
Even after all of their symptoms are gone, people who have had a concussion take longer to regain complex reaction times, the kind you need in most real-life driving situations on the road, according to a preliminary study released today that will be presented at the American Academy of Neurology's Sports Concussion Virtual Conference from July 31 to August 1, 2020.

Biomarkers may help us understand recovery time after concussion
A blood test may help researchers understand which people may take years to recover from concussion, according to a study published in the May 27, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Concussion alters how information is transmitted within the brain
Damage from concussion alters the way information is transmitted between the 2 halves of the brain, according to a new study.

Concussion recovery not clear cut for children
Sleep problems, fatigue and attention difficulties in the weeks after a child's concussion injury could be a sign of reduced brain function and decreased grey matter.

A concussion can cost your job -- especially if you are young and well educated
A seemingly harmless concussion can cause the loss of a job -- especially for patients who are in their thirties and for those with a higher education.

After concussion, biomarkers in the blood may help predict recovery time
A study of high school and college football players suggests that biomarkers in the blood may have potential use in identifying which players are more likely to need a longer recovery time after concussion, according to a study published in the July 3, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

Concussion is a leading cause of injury for children in recreational sports
In a two-year study of children between ages 5-11 who play recreational sports, more suffered concussions than most any other sports-related injury.

Concussion symptoms reversed by magnetic therapy
Concussion symptoms -- such as loss of balance and ability to walk straight -- can be reversed by a new type of magnetic stimulation

Study paves way for better treatment of lingering concussion symptoms
The results of the study, released in Neuroscience journal, show that significant levels of fatigue and poorer brain function can persist for months, or even years, following concussion.

Read More: Concussion News and Concussion Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.